Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Name: Prothena Corporation plc: Is Infosys Ltd. worth buying?
Item: Prothena Corporation plc
Rating: 1.92433325
Author: Trendlyne DVM scores

about

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amy...

9.45 0.14 (1.50%)

34.10% Fall from 52W High

5,304.6

XNAS Volume

XNAS 13 Mar, 2026 9:32 AM (EDT)

Not Eligible

Expensive Valuation

14.3 / 100

Technically Moderately Bullish

62.6 / 100

1Yr Price target upside is 117%

6 analysts

Prothena Corporation plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amy...

34.10% Fall from 52W High

SWOT Analysis

Prothena Corporation plc Live Price Chart